Subacute Sclerosing Panencephalitis in Two Brothers

Neuropediatrics

Volumn 34, Issue 6, 2003, Pages 326-329

  Vieker, S ^a,b   Schmitt, J J ^b   Behrens, C ^c   Weissbrich, B ^d   Hartmann, H ^c  

^a Gilead Hospital   (Germany)

^b EPILEPSY CENTER BETHEL   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Familial occurrence; Immunodeficiency; Subacute sclerosing panencephalitis; Vaccination

Indexed keywords

CARBAMAZEPINE; IMMUNOGLOBULIN G; MEASLES ANTIBODY; METHISOPRINOL;

ANAMNESIS; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BRAIN CELL; CASE REPORT; CHILD; DISEASE COURSE; ELECTROENCEPHALOGRAM; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; IMMUNOMODULATION; MALE; MEASLES; MEASLES VIRUS; MYOCLONUS; NEUROPATHOLOGY; PATHOGENESIS; PERSISTENT VEGETATIVE STATE; PRIORITY JOURNAL; SEIZURE; SIBLING; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS NUCLEOCAPSID;

CHILD; HUMANS; MALE; SIBLINGS; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 0347987826     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44672     Document Type: Article

References (14)

1. Anlar B, Saatçi I, Köse G, Yalaz K. MRI findings in subacute sclerosing panencephalitis. Neurology 1996; 47: 1278-1283
2. Anlar B, Yalaz K, Oktem F, Köse G. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular α-interferon. Neurology 1997; 48: 526-528
3. Bartram CR, Henke J, Treuner J, Basler M, Esch A, Mortier W. Subacute sclerosing panencephalitis in a brother and sister. Therapeutic trial of fibroblast interferon. Eur J Pediatr 1982; 138: 187-190
4. Britt WJ. Slow viruses. In: Feigin RD, Cherry JD (Eds). Textbook of Pediatric Infectious Diseases. Philadelphia, PA: WB Saunders Company, 1998: 1646-1665
5. Gascon GG. Subacute sclerosing panencephalitis. Semin Pediatr Neurol 1996; 3: 260-269
6. Gascon G, Yamani S, Crowell J, Stigsby B, Nester M, Kanan I et al. Combined oral isoprinosine-intraventricular α-interferon therapy for subacute sclerosing panencephalitis. Brain Dev 1993; 15: 346-355
7. Hara T, Yamashita S, Aiba H, Nihei K, Koide N, Good RA et al. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J Neurovirol 2000; 6: 121-126
8. Jin L, Beard S, Hunjan R, Brown DWG, Miller E. Characterization of measles virus strains causing SSPE: A study of 11 cases. J Neurovirol 2002; 8: 335-344
9. Lauberau B, Hermann M, Weil J, Schmitt HJ, von Kries R. Durchimpfungsraten von Kindern in Deutschland 1999. Monatsschr Kinderheilkd 2001; 149: 367-372
10. Park SY, Kohl S. Subacute sclerosing panencephalitis in an identical twin. Pediatrics 1999; 104: 1390-1394
11. Sidhu MS, Crowley J, Lowenthal A, Karcher D, Menonna J, Cook S et al. Defective measles virus in human subacute sclerosing panencephalitis brain. Virology 1994; 202: 631-641
12. Takahashi T, Hosoya M, Kimura K, Ohno K, Mori S et al. The cooperative effect of interferon-α and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo. Antiviral Res 1998; 37: 29-35
13. Tischer A, Siedler A, Santibanez S, Grüber A, Rasch G. Sind Masern in Deutschland noch ein Problem? Monatsschr Kinderheilkd 2002; 150: 1077-1086
14. Tomoda A, Shiraishi S, Hosoya M, Hamada A, Miike T. Combined treatment with interferon α and ribaverin for subacute sclerosing panencephalitis. Pediatr Neurol 2001; 24: 54-59